We describe three recombinant engineered antibodies against three recombinant epitope tags, constructed with divalent binding arms to recognize divalent epitopes and so achieve high affinity and specificity. In two versions, an epitope is inserted in tandem into a protein of interest, and a homodimeric antibody is constructed by fusing a high-affinity epitope-binding domain to a human or mouse Fc domain. In a third, a heterodimeric antibody is constructed by fusing two different epitope-binding domains which target two different binding sites in GFP, to polarized Fc fragments. These antibody/epitope pairs have affinities in the low picomolar range and are useful tools for many antibody-based applications
Organizer: Cambridge Healthtech Institute (CHI)With a rapid growth of the global protein purificatio...
Basic neuroscience research employs antibodies as key reagents to label, capture, and modulate the f...
AbstractFor more than 30years, the production of research antibodies has been dominated by hybridoma...
We describe three recombinant engineered antibodies against three recombinant epitope tags, construc...
Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We...
Only a small fraction of the antibodies in a traditional polyclonal antibody mixture recognize the t...
Recombinant human antibody technology has been the cornerstone of the uprising of biologics in the p...
Extensive studies of the structure–function relationship of antibodies have established that convent...
<p>(<b>A</b>) Binding of recombinant C11L34 antibody to a single or tandem GCN epitope placed within...
textThe development of recombinant proteins for therapeutic applications has revolutionized the phar...
Within the field of biologics, monoclonal antibodies have ruled the market with blockbuster and top ...
The biotech industry has seen an explosion in the development of therapeutic antibodies in the last ...
Different antibody derived constructs are rapidly advancing as putative tools for treatment of malig...
Antibodies are proteins produced by the immune system to combat pathogens and have long been apprec...
The isolation of mammalian cell lines capable of high-yield expression of recombinant antibodies is ...
Organizer: Cambridge Healthtech Institute (CHI)With a rapid growth of the global protein purificatio...
Basic neuroscience research employs antibodies as key reagents to label, capture, and modulate the f...
AbstractFor more than 30years, the production of research antibodies has been dominated by hybridoma...
We describe three recombinant engineered antibodies against three recombinant epitope tags, construc...
Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We...
Only a small fraction of the antibodies in a traditional polyclonal antibody mixture recognize the t...
Recombinant human antibody technology has been the cornerstone of the uprising of biologics in the p...
Extensive studies of the structure–function relationship of antibodies have established that convent...
<p>(<b>A</b>) Binding of recombinant C11L34 antibody to a single or tandem GCN epitope placed within...
textThe development of recombinant proteins for therapeutic applications has revolutionized the phar...
Within the field of biologics, monoclonal antibodies have ruled the market with blockbuster and top ...
The biotech industry has seen an explosion in the development of therapeutic antibodies in the last ...
Different antibody derived constructs are rapidly advancing as putative tools for treatment of malig...
Antibodies are proteins produced by the immune system to combat pathogens and have long been apprec...
The isolation of mammalian cell lines capable of high-yield expression of recombinant antibodies is ...
Organizer: Cambridge Healthtech Institute (CHI)With a rapid growth of the global protein purificatio...
Basic neuroscience research employs antibodies as key reagents to label, capture, and modulate the f...
AbstractFor more than 30years, the production of research antibodies has been dominated by hybridoma...